Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiichi Ishida

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Toxicology|March 17, 2022
Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS ProjectSeiichi Ishida
Drug Metabolism and Pharmacokinetics|February 6, 2018
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studiesSeiichi Ishida
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 3, 2019
[Microphysiological system as a promising technology for drug assay]Seiichi Ishida, Toshiyuki Kanamori
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 3, 2023
[Accelerate New Drug Development by Imitating the Biological Environment in Micro-space-The Cutting Edge of MPS from Japan]Daiju Yamazaki, Seiichi Ishida
Drug Metabolism and Pharmacokinetics|January 23, 2025
Global expansion of microphysiological systems (MPS) and Japan's initiatives: Innovation in pharmaceutical development and path to regulatory acceptanceDaiju Yamazaki, Seiichi Ishida
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|December 18, 2013
[Developing and standardizing experimental protocols using human iPS-derived cells to predict adverse drug reactions in pre-clinical safety studies]Yuko Sekino, Kaoru Sato, Yasunari Kanda, et al.
Pharmaceutics|January 21, 2023
Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver CharacteristicsShinichiro Horiuchi, Yukie Kuroda, Yuji Komizu, et al.
Drug Metabolism Letters|December 3, 2020
Recent Progress in Prediction Systems for Drug-induced Liver Injury Using In vitro Cell CultureShogo Ozawa, Toshitaka Miura, Jun Terashima, et al.
Cytotechnology|March 18, 2024
Selective elimination of tumorigenic cells from mixed culture of normal and tumorigenic cells using hybrid liposomes aimed at realizing of cell therapyRiko Jinno, Moe Tanaka, Yuji Komizu, et al.
Biochemical and Biophysical Research Communications|December 26, 2018
Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cellsKosuke Inamura, Yuji Komizu, Mami Yamakuchi, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Toxicology|March 17, 2022
Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS ProjectSeiichi Ishida
Drug Metabolism and Pharmacokinetics|February 6, 2018
Organs-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studiesSeiichi Ishida
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 3, 2019
[Microphysiological system as a promising technology for drug assay]Seiichi Ishida, Toshiyuki Kanamori
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 3, 2023
[Accelerate New Drug Development by Imitating the Biological Environment in Micro-space-The Cutting Edge of MPS from Japan]Daiju Yamazaki, Seiichi Ishida
Drug Metabolism and Pharmacokinetics|January 23, 2025
Global expansion of microphysiological systems (MPS) and Japan's initiatives: Innovation in pharmaceutical development and path to regulatory acceptanceDaiju Yamazaki, Seiichi Ishida
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|December 18, 2013
[Developing and standardizing experimental protocols using human iPS-derived cells to predict adverse drug reactions in pre-clinical safety studies]Yuko Sekino, Kaoru Sato, Yasunari Kanda, et al.
Pharmaceutics|January 21, 2023
Consideration of Commercially Available Hepatocytes as Cell Sources for Liver-Microphysiological Systems by Comparing Liver CharacteristicsShinichiro Horiuchi, Yukie Kuroda, Yuji Komizu, et al.
Drug Metabolism Letters|December 3, 2020
Recent Progress in Prediction Systems for Drug-induced Liver Injury Using In vitro Cell CultureShogo Ozawa, Toshitaka Miura, Jun Terashima, et al.
Cytotechnology|March 18, 2024
Selective elimination of tumorigenic cells from mixed culture of normal and tumorigenic cells using hybrid liposomes aimed at realizing of cell therapyRiko Jinno, Moe Tanaka, Yuji Komizu, et al.
Biochemical and Biophysical Research Communications|December 26, 2018
Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cellsKosuke Inamura, Yuji Komizu, Mami Yamakuchi, et al.
Pageof 7